4-BROMOESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROL 3,15,16,17-TETRAACETATE, (15.ALPHA.,16.ALPHA.,17.BETA.)-
UNII 98W7NL9TLF
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-bromoestra-1,3,5(10)-triene-3,15,16,17-tetrol 3,15,16,17-tetraacetate, (15.alpha.,16.alpha.,17.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 98W7NL9TLF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3109975-12-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H31BrO8 LPMBSCUGXFRXOB-OLWKIVFISA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-bromoestra-1,3,5(10)-triene-3,15,16,17-tetrol 3,15,16,17-tetraacetate, (15.alpha.,16.alpha.,17.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.